Amy Michelle Winkelman is a San Francisco, California based nurse practitioner who is specialized as Acute Care nurse. Her current practice location is 1001 Potrero Ave, San Francisco. Patients can reach her at 415-206-8000. Amy Michelle Winkelman is N.P. with specialization in Acute Care and her NPI number (Unique professional ID assigned by NPPES) is 1992036727. Amy Michelle Winkelman is a licensed independent practitioner and may autonomously provide care. She provides advanced nursing care across the continuum of health care services to meet the specialized physiologic and psychological needs of patients with acute, critical, and/or complex chronic health conditions. This care is continuous and comprehensive and may be provided in any setting where the patient may be found.
Complete Profile:
Amy Michelle Winkelman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Amy Michelle Winkelman
Specialization:
Acute Care Nurse Practitioner (ACNP)
Gender:
Female
Credentials:
N.P.
Practice Address:
1001 Potrero Ave, San Francisco, California, 94110-3518
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1992036727
NPI Enumeration Date:
19 Jan, 2010
NPI Last Update On:
19 Jan, 2010
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Amy Michelle Winkelman 50 Cole St, San Francisco, California
Zip:
94117-1114
Phone Number:
510-414-6896
Patients can reach Amy Michelle Winkelman at 1001 Potrero Ave, San Francisco, California or can call to book an appointment on 415-206-8000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.